Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1N-benzylamides Article

cited authors

  • Burgey, CS; Robinson, KA; Lyle, TA; Nantermet, PG; Selnick, HG; Isaacs, RCA; Lewis, SD; Lucas, BJ; Krueger, JA; Singh, R; Miller-Stein, C; White, RB; Wong, B; Lyle, EA; Stranieri, MT; Cook, JJ; McMasters, DR; Pellicore, JM; Pal, S; Wallace, AA; Clayton, FC; Bohn, D; Welsh, DC; Lynch, JJ; Yan, YW; Chen, ZG; Kuo, L; Gardell, SJ; Shafer, JA; Vacca, JP

authors

Publication Date

  • April 7, 2003

webpage

published in

category

start page

  • 1353

end page

  • 1357

volume

  • 13

issue

  • 7